BIIB•benzinga•
BMO Capital Downgrades Biogen to Market Perform, Lowers Price Target to $164
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 20, 2024 by benzinga